jc
jc

News Center

Check category
/
/
/
Thousands of heart valve disease gospel - 7 minutes surgery 3 days out of hospital, no surgery positioning minimally invasive J-Valve® technology listed

Thousands of heart valve disease gospel - 7 minutes surgery 3 days out of hospital, no surgery positioning minimally invasive J-Valve® technology listed

  • Categories:News Channel
  • Author:
  • Origin:
  • Time of issue:2017-06-09 14:16
  • Views:

(Summary description)

Thousands of heart valve disease gospel - 7 minutes surgery 3 days out of hospital, no surgery positioning minimally invasive J-Valve® technology listed

(Summary description)

  • Categories:News Channel
  • Author:
  • Origin:
  • Time of issue:2017-06-09 14:16
  • Views:
Information

X

 

  On June 8, 2017, Suzhou Jincheng Medical Technology held a "J-Valve? Interventional Biofilm" conference in Beijing, announcing the "J-Valve? 2 Annual Clinical Study" at the scene, highlighting the innovative " There are positioning devices for heart valve implantation system J-Valve? "How to" solve the aortic valve disease in one stop ", the live media and guests respond enthusiastically.

 

X

 

  "J-Valve? Involved in Artificial Bio Valve"
  Heart valve, Prince of the hands of the shield


  Heart, the foundation of this life, is to control all the princes, but also illuminate the world of the sun, no it is difficult to survive the biological, the organ is the vitality of the source of power - Dr. William Harvey 1628 letter King Charles I The
  In 1628, Harvey published "Anatomy of the heart and blood movement in the body". This book is not only the West, and even the history of human medicine Juxian, also opened a new era of heart research. "The blood is constantly circulating in the body every week, and this cycle relies on heart compression to achieve the goal, which is the only reason for heart beat."
  Based on Harvey theory, humans understand the causes of heart disease. 1895 X-ray come out, the heart of the formation, the human heart is like the middle of the chest two side by side leaning on the pump, the two pumps up and down each have a chamber, the above is the blood of the atrium, the following is squeezed bleeding ventricular, Between the atrium and the ventricles have a one-way valve, so that the blood can only flow in one direction, if the heart is to control all the prince, the heart valve is the hands of the shield of the prince.
  "Valve is the heart of a door, only the door can be smooth opening and closing, smooth, the heart can be healthy and effective blood supply, once the valve stenosis or can not be closed, the heart will be lack of power failure." Painstaking research heart, focus on valve research Dr. Zhang Zhang shared the theme of "a decade of sword, my creative heart" as the theme of the road of scientific research, and broadcast the "new generation of interventional valve J-Valve? exploration of the road" short film.
  Heart failure has become the world's largest cause of death
  The heart valve disease is the main cause of heart failure
  Authoritative data show that heart failure has become the world's largest cause of death. And heart valve stenosis and can not be closed is one of the most important causes of heart failure, the world's existing heart valve patients 12 million, each year nearly 100 million people died, China is a high incidence of heart disease, with more than 2 million patients , The need for surgical patients more than 200,000 per year. But the real treatment of patients with less than 1 / 3. China each year, 150,000 patients lost surgery opportunities.

 

X

 

Fuwai Hospital, Department of Cardiac Surgery, Professor Wang Wei, director of minimally invasive center


  Professor Wang Wei, Director of the Department of Cardiac Surgery, Department of Cardiac Surgery, Fuwai Hospital, today announced that the current universal and traditional method of valve therapy is through the traditional replacement of heart valve surgery, namely: "Chinese heart valve disease treatment yesterday, today and tomorrow" Thoracotomy, incision of the heart, cardiopulmonary bypass, cardiac arrest, suture the valve. Need to neck below the chest out of 30 cm long incision, with the doctor's technology to manually replace the valve, the general operation time up to 3 to 4 hours, the patient needs to endure great pain and blood loss.
  "This is not just a matter of money, the situation in the world is the same. Limited medical conditions and the patient's ability to accept surgery is mutual."
  Zhang went to Canada to overcome the world problems
  In order to overcome the heart of the heart of this problem, Zhang Lei 37 years only to do one thing - the study of the heart, the pursuit of each person's heart can jump more healthy.

 

X

 

  Suzhou Jincheng Medical Technology Co., Ltd. founder


  "J-Valve heart valve" patent inventor Dr. Zhang Ji
  Zhang, China's first generation of science from the heart of the surgeon, 28-year-old became the Beijing People's Hospital attending physician, in 1991 alone went to Canada under the tutelage of Columbia University Professor Sam, painstaking research on heart surgery, has won more than 10 world patents, "The heart valve implantation system with active positioning device - J-Valve? intervenes in artificial valve" is the most characteristic.
  "J-Valve? Interventional Artificial Bio Valve" is favored by medical researchers in the United States and Canada, and they have thrown an olive branch from Zhang, hoping to apply the technology transfer to the North American market. Zhang insisted on the beginning, refused the invitation of the United States and Canada, with their own patent to return home.
  Focus on the valve research at the same time, Zhang has served as president of the Canadian Cardiac Surgery Consultants, JMD Innovation's chief executive officer, has two professional heart support company executives experienced a great impact on Zhang, "this 10 years Of the research and related business management and operation, so I set up their own unique production and research with the professional system.
  September 2009, by the local government investment invitation, Zhang decided to return to Suzhou Wujiang Industrial Park, the most proud of their own valve replacement technology research results brought back to the motherland "ground to take root." "This technology is leading in the world. Less than 30 minutes of the demo, so I won the investment," Zhang Zhang then changed the five technical products, "is now the sixth generation, the successful completion of animal experiments and more than 100 cases Clinical case treatment, the effect is extraordinary, I am very proud.


J-Valve? Intervenes in Artificial Bio Valve System
By the State Food and Drug Administration approved the listing

 

X

 

  "J-Valve? Interventional Biofilm System" has been successfully launched


  According to reports, Suzhou Jincheng Medical Technology Co., Ltd. independently developed "J-Valve? involved in artificial bio-valve" by the State Food and Drug Administration approved the listing. "This is China's first original and has a leading international intellectual property involved in the heart valve, is currently the world's only can, but also the first of its kind in patients with aortic stenosis, aortic valve regurgitation, Effective minimally invasive treatment of aortic valve insufficiency or stenosis of the solution.
  "J-Valve? Interventional Artificial Bio Valve" is an innovative special approval project of the State Administration of Food and Drug Administration's "Special Approval Procedures for Innovative Medical Devices (Trial)". The technology from the "National Thousand Program" invited experts and a number of international senior professionals based on years of experience in research and development, is the first time in China to the Western developed countries successfully exported high-end medical technology. "J-Valve? intervention in artificial bio-valve" listed on the approval of the country fully reflects the innovation, promote the implementation of medical equipment localization policy.


One-stop solution for aortic valve
Benefit the world tens of millions of heart valve patients

 

X

 

  Professor Guo Yingjiang, Deputy Director of Cardiothoracic Surgery, West China Hospital, Sichuan University
  In the evening of May 2017, "J-Valve? Involved in Artificial Bio-valve" was held at Huaxi Hospital of Sichuan University, Zhongshan Hospital of Fudan University in Shanghai, Chinese medicine, and so on. Academy of Sciences Fu Wai Cardiovascular Hospital, have completed the established number of clinical trials. Clinical study data show that J-Valve? has a full-cause mortality of only 5.6% at 12 months after aortic valve involvement and only 4.6% of permanent pacemaker implantation, well below the global average. Excellent clinical trial performance by the industry well-known magazine "American Journal of Cardiology" (JACC) published, a sensation in the global field of heart care. In addition, the technology was also introduced to the St. Paul's Hospital in Vancouver, Canada, the Chinese Embassy in Canada highly praised.
  At present, the United States listed two minimally invasive heart valve implantation system, but there is no comprehensive positioning device, "J-Valve? intervention artificial bio-valve" is the world's only intelligent three-dimensional positioning of the heart valve system. The system is different from the traditional thoracotomy treatment of heart valve disease of a minimally invasive surgical technique, with no surgery, short time, low cost, simple operation process, technical requirements are not high, completely rely on the implantation of the system itself to complete the positioning device valve Replacement surgery, thereby reducing the risk of surgery, so that patients receive timely treatment and other advantages.
  "J-Valve? Interventional Artificial Bio Valve" is the world's most advanced valve disease treatment technology, Jacheng developed technology products to solve the heart valve disease this world-class problems. At present, the technology has been initially in the field of valvular surgery in China to form a new treatment norms, the use of "J-Valve? interventional artificial biological valve" technology for aortic valve replacement takes only 7 to 10 minutes, the fastest to reach 2 Min, and clinical trials were high-risk elderly patients, the average age of 74 years of age, the highest age of 87 years of age.
  The world's leading technology, intelligent positioning system, the operation process is simple, quality and safety of the double protection, the technology in the medical field of extraordinary significance for the country and the global heart valve patients really benefit.

 

X

 

  Interview with Professor Zheng Zhe, Deputy Director of National Cardiovascular Center


  About Jincheng Medical
  Jincheng medical technology company is a completely independent intellectual property rights of the minimally invasive medical technology company, and patented technology in a leading position in the company was founded in September 2009, the research team from Canada to return Dr., heart surgery experts Zhang A number of foreign senior professionals, the company led the project is a new "with positioning device heart valve implantation system - J-Valve? interventional artificial bio-valve" technology research and development and product production.
  "For heart valve disease, J-Valve? technology products are currently the best treatment regimen, no one," Zhang said.

 

X

Contact us

这是描述信息

+86-512-63179788(WJ) | +86-512-63036288(SZ)

这是描述信息

Building4-1,Hi-Tech Park, Wujiang, Jiangsu Province, China

C21 Building, 218 Xinghu Street, Suzhou Industrial Park, China

这是描述信息

215200

FOLLOW US

这是描述信息

Mobile Website

这是描述信息

WeChat

Copyright ©  Suzhou Jiecheng Medical Technology Co., Ltd. 

这是描述信息